Ysios Capital
Ysios Capital
Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide.
- Use: Go2Market;
- Date closing: -
- Amount: -
- Industry focus: Health;
- Total budget: 216M €
- Entity type: Venture Capital
- Vertical focus: biotechnology, emerging pharmaceuticals, healthcare and medical technology
- Website: http://www.ysioscapital.com/
- Status: Open
- Funding type: Equity investment;
- Geographic focus: Europe;
- Public/Private: Private
- Stage focus: Seed; Series A; Series B;
- Applicant target: Startup;
Overview
Ysios Capital provides biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs.
They invest in companies that will have a positive impact on patients and society and in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need.
Ysios Capital has raised a total of €411.4M across 3 funds, their latest being Ysios BioFund III. This fund was announced on Jun 10, 2020 and raised a total of €216M.
Last updated on 2023-05-04 11:52
Ysios Capital FAQ
0 questions
Ysios Capital Reviews
0 reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
0 Average
Ysios Capital News
Featured Funds
- Usage: R&D; Go2Market;
- Entity type: Public Agency
- Funding type: Grant;
- Geographic focus: Sweden;
- 0 reviews 0 questions
.jpg)
- Usage: R&D; Go2Market;
- Entity type: Public Agency
- Total: 1B €
- Funding type: Grant; Equity investment;
- Status: Open
- Geographic focus: Horizon Europe associated countries; European Union;
- 2 reviews 76 questions
- Usage: Go2Market;
- Entity type: Accelerator
- Funding type: Crowdfunding; Equity investment; In kind; Other;
- Status: Open
- 0 reviews 0 questions
Login or create an account. It's free and very fast